AskMed

HEART score interpretation: what each score from 0 to 10 means

A HEART score runs from 0 to 10. Here is the risk of a major adverse cardiac event in each band in the three studies that built and validated the score, what their authors linked to each band, how the HEART Pathway adds a second troponin, and how accurate each cut-off is.

Open the HEART score calculator

What a HEART score means

A HEART score is the sum of five items scored 0, 1 or 2 points each, so it runs from 0 to 10, and it estimates the short-term risk of a major adverse cardiac event (MACE) in a patient who comes to the emergency department with chest pain. The items are History, ECG, Age, Risk factors and Troponin. Six, Backus and Kelder described the score in the Netherlands Heart Journal in 2008 and split the totals into three bands: 0 to 3 points, 4 to 6 points and 7 to 10 points. The largest test of those bands was the 2013 prospective validation by Backus and colleagues, in 2,388 unselected chest pain patients at 10 Dutch hospitals, where MACE within 6 weeks occurred in 1.7% of low scores, 16.6% of moderate scores and 50.1% of high scores. MACE there meant acute myocardial infarction, PCI, CABG, coronary angiography showing a procedurally correctable stenosis managed conservatively, or death from any cause.

HEART score bands and 6-week MACE 0 1 2 3 4 5 6 7 8 9 10 Low Moderate High 1.7% 16.6% 50.1% 15 of 870 183 of 1101 209 of 417 Share of patients: 36.4% · 46.1% · 17.5%
HEART score bands with the share of patients and the rate of major adverse cardiac events within 6 weeks in each, from the 2013 prospective validation of 2,388 patients (Backus et al.). The HEART score calculator shows the same figures.

The three Dutch studies found the same rising pattern, with different rates in each band. The 2008 pilot followed 120 patients at one hospital for AMI, PCI, CABG or death, all of which occurred within 3 months; the 2010 retrospective study and the 2013 prospective validation counted events within 6 weeks.

HEART scoreSix 2008 (120 patients)Backus 2010 (880 patients)Backus 2013 (2,388 patients)
0–3 · Low2.5% (1 of 39)0.99% (3 of 303)1.7% (15 of 870)
4–6 · Moderate20.3% (12 of 59)11.6% (48 of 413)16.6% (183 of 1101)
7–10 · High72.7% (16 of 22)65.2% (107 of 164)50.1% (209 of 417)

The HEART score calculator uses the 2013 figures, the largest and only prospective set of the three.

HEART score of 0 to 3: low risk

A HEART score of 0, 1, 2 or 3 places a chest pain patient in the low-risk band. In the 2013 validation, 870 of 2,388 patients (36.4%) scored 0 to 3, and 15 of them (1.7%) had a major adverse cardiac event within 6 weeks. The 2008 pilot found 1 event among 39 low scores (2.5%), a bypass operation 11 days after admission, and the 2010 retrospective study found 3 among 303 (0.99%). Backus and colleagues wrote in 2013 that a low score excludes short-term MACE with more than 98% certainty and that reserved policies may be considered in these patients. The 2008 paper said a low score supports a policy of early discharge, and doubted that further tests at the outpatient clinic would be useful. A low score is not the same as a negative troponin, though: a patient can score 3 with 1 troponin point, which is why the HEART Pathway also asks for normal troponin results at 0 and 3 hours.

A score of 3 can also describe very different patients. A 40-year-old with a highly suspicious history and one risk factor scores 3 (2 + 0 + 0 + 1 + 0), and so does a 70-year-old with a non-suspicious history, a normal ECG, one risk factor and a normal troponin (0 + 0 + 2 + 1 + 0). Age alone gives 2 points from 65 onwards.

HEART score of 4 to 6: moderate risk

A HEART score of 4, 5 or 6 is the moderate band, which the 2013 paper calls intermediate risk, and it holds the largest share of chest pain patients. In the 2013 validation, 1,101 of 2,388 patients (46.1%) scored 4 to 6, and 183 of them (16.6%) had a major adverse cardiac event within 6 weeks. The 2008 pilot found 12 events in 59 patients (20.3%), and the 2010 study 48 in 413 (11.6%). Six and colleagues wrote in 2008 that immediate discharge is not an option at these scores: patients should be admitted for clinical observation, treated as an acute coronary syndrome awaiting a final diagnosis, and given noninvasive tests such as repeated troponin, exercise testing and possibly advanced ischaemia detection. In the HEART Pathway trial, any score of 4 or more counted as high risk and led to objective cardiac testing in hospital or an observation unit.

A worked example: the HEART score calculator opens on a score of 4, from a moderately suspicious history, a nonspecific repolarization disturbance on the ECG, an age over 45 and under 65, and one or two risk factors (1 point each), with a troponin at or below the normal limit (0). It shows moderate risk and a 6-week MACE rate of 16.6%. A score of 4 needs no acute finding at all: a patient aged 65 or over with three risk factors has 4 points before the history, ECG or troponin is scored.

HEART score of 7 to 10: high risk

A HEART score of 7 or more is the high-risk band, where half of patients had a major adverse cardiac event in the 2013 validation. There, 417 of 2,388 patients (17.5%) scored 7 to 10, and 209 of them (50.1%) had MACE within 6 weeks. Event rates in this band were higher in the two earlier, smaller studies: 16 of 22 patients (72.7%) in the 2008 pilot and 107 of 164 (65.2%) in the 2010 retrospective study. The 2008 paper said a score of 7 or more implies early aggressive treatment, including invasive strategies without preceding noninvasive testing, and the 2013 paper said the high risk may indicate more aggressive policies. Because MACE in these studies counts PCI and CABG, part of the high event rate reflects the procedures that high-risk patients went on to have. In the 2008 pilot, both patients who died during follow-up, two men aged 78, had a HEART score of 8.

The HEART Pathway: the score plus serial troponin

The HEART Pathway combines the HEART score with troponin tests at 0 and 3 hours to identify emergency department chest pain patients who can go home early. Mahler and colleagues tested it against usual care in a randomized trial of 282 adults at a US academic medical center, published in 2015. In the pathway, a score of 0 to 3 with negative troponins at 0 and 3 hours was low risk, and the recommendation was discharge from the emergency department without further testing, with follow-up by the patient's primary care provider. A score of 4 or more, or a troponin above the 99th percentile, was high risk and led to objective cardiac testing in hospital or an observation unit. Of the 141 patients in the pathway arm, 66 (46.8%) were low risk. Compared with usual care, the pathway cut objective cardiac testing at 30 days from 68.8% to 56.7% and raised early discharge from 18.4% to 39.7%, and no low-risk patient had MACE.

The trial was small: 6% of all participants had MACE within 30 days, and doctors did not follow the pathway for 19 of the 66 low-risk patients, none of whom had an event. Its MACE was death, myocardial infarction or coronary revascularization within 30 days, a narrower outcome than in the Dutch studies. For how HEART compares with older chest pain scores, see HEART vs TIMI vs GRACE.

How accurate each HEART score cut-off is

Each HEART score cut-off trades sensitivity against specificity. Fernando and colleagues pooled 30 studies with 44,202 emergency department chest pain patients in a 2019 systematic review and meta-analysis in Academic Emergency Medicine. A score of 4 or more, the line above the low-risk band, had a sensitivity of 95.9% and a specificity of 44.6% for MACE within 30 days or 6 weeks. A score of 7 or more had a sensitivity of 39.5% and a specificity of 95.0%. So the low-risk cut-off misses few events but places more than half of the patients who have no event in the moderate band or above, while the high-risk cut-off is specific but catches fewer than half of all events. In the same review, a TIMI score of 2 or more had a sensitivity of 87.8% and a specificity of 48.1%. The authors concluded that HEART should be the primary decision instrument for risk stratification of emergency chest pain.

Cut-offSensitivity for MACESpecificity for MACE
HEART 4 or more95.9%44.6%
HEART 7 or more39.5%95.0%
TIMI 2 or more87.8%48.1%

Limits of HEART score interpretation

A HEART score band is only as reliable as the five judgements behind it. The history item has no fixed definition: Six and colleagues wrote in 2008 that patient history is subject to personal interpretation, and in the HEART Pathway trial two attending physicians scoring the same patients agreed on low versus high risk with a kappa of 0.63, above the trial's 0.60 threshold for acceptable agreement. Age and risk factors carry up to 4 points, so older patients with several risk factors reach the moderate band without any acute finding. The troponin item counts only the first sample against the normal limit of the assay, and the 2008 pilot used a conventional troponin I assay. The score was not built for ST-elevation myocardial infarction: in the 2008 pilot, patients with ST elevation in the ambulance went straight to a catheter laboratory at another hospital and were not studied. Because PCI and CABG count as events, the band rates also reflect local practice at the study hospitals.

Questions

What does a HEART score of 3 mean?

A score of 3 is the top of the low-risk band, 0 to 3. In the 2013 validation, 1.7% of patients scoring 0 to 3 had a major adverse cardiac event within 6 weeks. In the HEART Pathway, a score of 3 counts as low risk only when troponins at 0 and 3 hours are also negative.

What does a HEART score of 4 mean?

A score of 4 is the bottom of the moderate band, 4 to 6, where 16.6% had MACE within 6 weeks in 2013. The 2008 paper advised admission for clinical observation at these scores, and the HEART Pathway sends patients scoring 4 or more for objective cardiac testing.

Why do the event rates differ between the HEART studies?

The 2008 pilot had 120 patients at one hospital, the 2010 study 880 patients reviewed retrospectively, and the 2013 validation 2,388 patients followed prospectively at 10 hospitals, with a broader MACE definition that included angiography showing a correctable stenosis. Smaller samples give less stable rates, especially in the high band.

Is the HEART score for patients with ST elevation?

No. The score was built for undifferentiated chest pain. Patients with ST-elevation myocardial infarction were not part of the 2008 study, and new ST elevation of 1 mm or more excluded patients from the HEART Pathway trial.

Can AskMed explain a HEART score with sources?

Yes. AskMed answers from guidelines and journals, with a citation after every claim, and does not give doses. It is on the App Store and Google Play, or use it on the web.

Sources

  1. Six AJ, Backus BE, Kelder JC. Chest pain in the emergency room: value of the HEART score. Neth Heart J. 2008;16(6):191–196. doi:10.1007/BF03086144
  2. Backus BE, Six AJ, Kelder JC, et al. Chest pain in the emergency room: a multicenter validation of the HEART Score. Crit Pathw Cardiol. 2010;9(3):164–169. doi:10.1097/HPC.0b013e3181ec36d8
  3. Backus BE, Six AJ, Kelder JC, et al. A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol. 2013;168(3):2153–2158. doi:10.1016/j.ijcard.2013.01.255
  4. Mahler SA, Riley RF, Hiestand BC, et al. The HEART Pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge. Circ Cardiovasc Qual Outcomes. 2015;8(2):195–203. doi:10.1161/CIRCOUTCOMES.114.001384
  5. Fernando SM, Tran A, Cheng W, et al. Prognostic accuracy of the HEART score for prediction of major adverse cardiac events in patients presenting with chest pain: a systematic review and meta-analysis. Acad Emerg Med. 2019;26(2):140–151. doi:10.1111/acem.13649

Cited medical answers
you can trust.

AskMed on iPhone, iPad, Android and the web.